All Stories

  1. Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported information

    Article • PLoS ONE, October 2021, PLOS

    Professor David Price

  2. Late Breaking Abstract - Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone

    Article • September 2021, European Respiratory Society (ERS)

    Professor David Price

  3. Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY

    Article • September 2021, European Respiratory Society (ERS)

    Professor David Price

  4. Late Breaking Abstract - Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)

    Article • September 2021, European Respiratory Society (ERS)

    Professor David Price

  5. Blood eosinophil count predicts treatment failure and hospital readmission for COPD

    Article • ERJ Open Research, October 2020, European Respiratory Society (ERS)

    Professor David Price

  6. Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety

    Article • European Respiratory Review, March 2020, European Respiratory Society (ERS)

    Professor David Price

  7. Management Of Community-Acquired Pneumonia: An Observational Study In UK Primary Care

    Article • Pragmatic and Observational Research, September 2019, Taylor & Francis

    Chris Winchester, Professor David Price, Dermot Ryan

  8. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2019, Dove Medical Press

    Prof Richard W Costello, ms Monica J Fletcher, Dr FEDERICO Lavorini, Prof Robert RODRIGUEZ-ROISIN, Professor David Price, Dermot Ryan

  9. Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2019, Dove Medical Press

    Dr Marc Miravitlles, Prof Richard W Costello, Victoria Carter, Bernardino Alcazar Navarrete, Dr Juan José Soler-Cataluña, Professor David Price, Chin Kook Rhee

  10. Comparative effectiveness of triple therapy versus dual bronchodilation in COPD

    Article • ERJ Open Research, July 2019, European Respiratory Society (ERS)

    Professor David Price

  11. Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks

    Article • Journal of Asthma and Allergy, December 2018, Dove Medical Press

    Jonathan Grigg, Professor David Price

  12. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2018, Dove Medical Press

    Professor David Price, Sinthia Bosnic-Anticevich

  13. Management of allergic rhinitis in the community pharmacy: identifying the reasons behind medication self-selection

    Article • Pharmacy Practice, September 2018, Centro de Investigaciones y Publicaciones Farmaceuticas (CIPF)

    Professor David Price

  14. Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data

    Article • Pragmatic and Observational Research, August 2018, Dove Medical Press

    Alexandra Dima, Professor David Price, Todor Popov, Helen Reddel

  15. Predicting frequent COPD exacerbations using primary care data [Corrigendum]

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2018, Dove Medical Press

    Professor David Price

  16. Real-life treatment of rhinitis in Australia: a historical cohort study of prescription and over-the-counter therapies for patients with and without additional respiratory disease

    Article • Pragmatic and Observational Research, August 2018, Dove Medical Press

    Professor David Price, Professor Peter Kenneth Smith, Victoria Carter, Sinthia Bosnic-Anticevich

  17. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study

    Article • Journal of Asthma and Allergy, August 2018, Dove Medical Press

    Professor David Price

  18. Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study

    Article • npj Primary Care Respiratory Medicine, July 2018, Springer Science + Business Media

    Professor David Price

  19. Health care resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma

    Article • Allergy, July 2018, Wiley

    Professor David Price

  20. Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey [Erratum]

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2018, Dove Medical Press

    Professor David Price

  21. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study

    Article • BMC Pulmonary Medicine, June 2018, Springer Science + Business Media

    Professor David Price, Guilherme Safioti

  22. Exogenous sex steroid hormones and asthma in females: protocol for a population-based retrospective cohort study using a UK primary care database

    Article • BMJ Open, June 2018, BMJ

    Professor David Price, Professor Colin R Simpson, Catherine Hawrylowicz

  23. Trends of testing for and diagnosis of α 1 -antitrypsin deficiency in the UK: more testing is needed

    Article • European Respiratory Journal, May 2018, European Respiratory Society (ERS)

    Professor David Price

  24. Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations

    Article • New England Journal of Medicine, March 2018, New England Journal of Medicine (NEJM/MMS)

    Professor David Price

  25. The Burden of Rhinitis and the Impact of Medication Management within the Community Pharmacy Setting

    Article • The Journal of Allergy and Clinical Immunology In Practice, March 2018, Elsevier

    Professor David Price

  26. Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2018, Dove Medical Press

    Professor David Price

  27. Real-life effectiveness and safety of salbutamol Steri-Neb™ vs. Ventolin Nebules® for exacerbations in patients with COPD: Historical cohort study

    Article • PLoS ONE, January 2018, PLOS

    Professor David Price

  28. Matching Inhaler Devices with Patients: The Role of the Primary Care Physician

    Article • Canadian Respiratory Journal, January 2018, Hindawi Publishing Corporation

    Professor David Price

  29. The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship

    Article • Pragmatic and Observational Research, December 2017, Dove Medical Press

    Professor David Price, Dr Christopher S Ambrose

  30. The effect of smoking on exacerbation risk in eosinophilic patients with COPD

    Article • European Respiratory Journal, December 2017, European Respiratory Society (ERS)

    Professor David Price

  31. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Article • Journal of the American Medical Directors Association, December 2017, Elsevier

    Dr Dimitar Sajkov, Professor David Price

  32. Author Correction: The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis

    Article • npj Primary Care Respiratory Medicine, December 2017, Nature

    Professor David Price

  33. FGF8 morphogen gradients are differentially regulated by heparan sulphotransferases Hs2st and Hs6st1 in the developing brain

    Article • Biology Open, November 2017, The Company of Biologists

    Professor David Price

  34. Modelling the effect of beliefs about asthma medication and treatment intrusiveness on adherence and preference for once-daily vs. twice-daily medication

    Article • npj Primary Care Respiratory Medicine, November 2017, Nature

    Professor David Price

  35. Identifying Patient Attitudinal Clusters Associated With Asthma Control: The European REALISE Survey

    Article • The Journal of Allergy and Clinical Immunology In Practice, November 2017, Elsevier

    Professor David Price

  36. Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population

    Article • Thorax, September 2017, BMJ

    Professor David Price

  37. A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2017, Elsevier

    Professor David Price

  38. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2017, Dove Medical Press

    Professor David Price

  39. Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study

    Article • Pragmatic and Observational Research, August 2017, Dove Medical Press

    Professor Peter Kenneth Smith, Professor David Price, Victoria Carter, Sinthia Bosnic-Anticevich

  40. Effective deployment of technology-supported management of chronic respiratory conditions: a call for stakeholder engagement

    Article • Pragmatic and Observational Research, July 2017, Dove Medical Press

    Prof Richard W Costello, Professor David Price, Andrew McIvor, Dermot Ryan

  41. Blood eosinophil count and exacerbation risk in patients with COPD

    Article • European Respiratory Journal, July 2017, European Respiratory Society (ERS)

    Professor David Price

  42. Asthma referrals: a key component of asthma management that needs to be addressed

    Article • Journal of Asthma and Allergy, July 2017, Dove Medical Press

    Professor David Price

  43. Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids

    Article • PLoS ONE, June 2017, PLOS

    Professor David Price

  44. Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases

    Article • Journal of Asthma and Allergy, May 2017, Dove Medical Press

    Professor Peter Kenneth Smith, Professor David Price, Victoria Carter, Sinthia Bosnic-Anticevich

  45. Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database

    Article • Pragmatic and Observational Research, May 2017, Dove Medical Press

    Professor David Price

  46. Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy

    Article • European Respiratory Journal, May 2017, European Respiratory Society (ERS)

    Professor David Price, Job van Boven

  47. Inhaler technique mastery and maintenance in healthcare professionals trained on different devices

    Article • Journal of Asthma, April 2017, Taylor & Francis

    Dr FEDERICO Lavorini, Professor David Price, Sinthia Bosnic-Anticevich

  48. Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations: USA Observational Cohort Study Using the Clinformatics™ Health Claims Database

    Article • Pulmonary Therapy, April 2017, Springer Science + Business Media

    Professor David Price

  49. Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

    Article • Pragmatic and Observational Research, April 2017, Dove Medical Press

    Dr Marc Miravitlles, Professor David Price, Job van Boven, Dermot Ryan

  50. Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study

    Article • Clinical Epidemiology, April 2017, Dove Medical Press

    Professor David Price, Jens Dollerup

  51. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK

    Article • BMJ Open, April 2017, BMJ

    Professor David Price

  52. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis

    Article • npj Primary Care Respiratory Medicine, March 2017, Nature

    Professor David Price

  53. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2017, Dove Medical Press

    Professor David Price, Dr. Konstantinos Kostikas, giovanni bader

  54. An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

    Article • Pragmatic and Observational Research, March 2017, Dove Medical Press

    Professor David Price

  55. Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profiles

    Article • npj Primary Care Respiratory Medicine, January 2017, Nature

    Professor David Price

  56. Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids

    Article • Allergy Asthma and Immunology Research, January 2017, The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

    Professor David Price

  57. Urinary prostanoids in preschool wheeze

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Professor David Price, Prof. John W Holloway, Professor Marek Sanak

  58. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2016, Dove Medical Press

    Dr FEDERICO Lavorini, Prof Richard W Costello, Prof Robert RODRIGUEZ-ROISIN, ms Monica J Fletcher, Professor David Price, Dermot Ryan

  59. Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2016, Dove Medical Press

    Professor David Price

  60. What We Mean When We Talk About Adherence in Respiratory Medicine

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2016, Elsevier

    Professor David Price

  61. UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study

    Article • npj Primary Care Respiratory Medicine, June 2016, Nature

    Professor David Price

  62. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets

    Article • npj Primary Care Respiratory Medicine, April 2016, Nature

    Professor David Price

  63. Add-on LABA in a separate inhaler as asthma step-up therapyversusincreased dose of ICS or ICS/LABA combination inhaler

    Article • ERJ Open Research, April 2016, European Respiratory Society (ERS)

    Professor David Price

  64. Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2015, Elsevier

    Professor David Price

  65. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2014, Taylor & Francis

    Ms Anne E Burden, Professor David Price, Jonathan Grigg

  66. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2014, Taylor & Francis

    Dr Marc Miravitlles, Professor ANDREA ROSSI, Mrs Catherine A Hutton, Mr Daniel J West, Professor David Price

  67. Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis

    Article • The Journal of Allergy and Clinical Immunology In Practice, March 2014, Elsevier

    Professor David Price

  68. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study

    Article • BMJ Open Respiratory Research, January 2014, Springer Science + Business Media

    Professor David Price

  69. Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach

    Article • Respiratory Medicine, December 2013, Elsevier

    Professor David Price

  70. Impact of night-time symptoms in COPD: a real-world study in five European countries

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2013, Taylor & Francis

    Professor David Price

  71. Challenges of COPD diagnosis

    Article • Expert Opinion on Medical Diagnostics, October 2013, Informa Healthcare

    Professor David Price

  72. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone

    Article • Journal of Allergy and Clinical Immunology, July 2013, Elsevier

    Professor David Price

  73. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma

    Article • Respiratory Medicine, July 2013, Elsevier

    Professor David Price

  74. The BREATHE study: Breathing REtraining for Asthma — Trial of Home Exercises. A protocol summary of a randomised controlled trial

    Article • Primary Care Respiratory Journal, May 2013, Nature

    Professor David Price

  75. A UK-Based Cost-Utility Analysis of Indacaterol, A Once-Daily Maintenance Bronchodilator for Patients with COPD, Using Real World Evidence on Resource Use

    Article • Applied Health Economics and Health Policy, March 2013, Springer Science + Business Media

    Professor David Price

  76. InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients - the LIAISON study protocol

    Article • BMC Pulmonary Medicine, March 2013, Springer Science + Business Media

    Professor David Price

  77. Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study

    Article • Primary Care Respiratory Journal, March 2013, Nature

    Professor David Price

  78. Effect of montelukast for treatment of asthma in cigarette smokers

    Article • Journal of Allergy and Clinical Immunology, March 2013, Elsevier

    Professor David Price

  79. GOLD COPD categories are not fit for purpose in primary care

    Article • The Lancet Respiratory Medicine, March 2013, Elsevier

    Professor David Price

  80. A BOLD statement on how to case-find moderate/severe COPD

    Article • European Respiratory Journal, February 2013, European Respiratory Society (ERS)

    Professor David Price

  81. Efficacy versus effectiveness trials

    Article • Current Opinion in Allergy and Clinical Immunology, February 2013, Wolters Kluwer Health

    Professor David Price

  82. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety

    Article • Health Technology Assessment, February 2013, National Institute for Health Research

    Professor David Price

  83. What we should learn from the London Olympics

    Article • Current Opinion in Allergy and Clinical Immunology, February 2013, Wolters Kluwer Health

    Professor David Price

  84. Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling

    Article • PharmacoEconomics, January 2013, Springer Science + Business Media

    Professor David Price

  85. Inhaler competence in asthma: Common errors, barriers to use and recommended solutions

    Article • Respiratory Medicine, January 2013, Elsevier

    Professor David Price

  86. Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis

    Article • International Archives of Allergy and Immunology, January 2013, Karger Publishers

    Professor David Price

  87. Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma

    Article • Respiratory Medicine, December 2012, Elsevier

    Professor David Price

  88. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD

    Article • Primary Care Respiratory Journal, November 2012, Nature

    Professor David Price

  89. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    Article • Journal of Allergy and Clinical Immunology, November 2012, Elsevier

    Dr Ioana O Agache, Professor David Price, Dr Giorgio Ciprandi, Adnan Custovic

  90. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis

    Article • Allergy and Asthma Proceedings, November 2012, Oceanside Publications Inc.

    Professor David Price

  91. The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care

    Article • Thorax, August 2012, BMJ

    Professor David Price

  92. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety

    Article • Allergy and Asthma Proceedings, July 2012, Oceanside Publications Inc.

    Professor David Price

  93. Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study

    Article • Primary Care Respiratory Journal, June 2012, Nature

    Professor David Price

  94. International consensus on (ICON) pediatric asthma

    Article • Allergy, June 2012, Wiley

    Dr Jose A. Castro-Rodriguez, Professor Göran Wennergren, Professor David Price, Adnan Custovic

  95. Asthma at-risk registers — can be effective if carefully constructed and correctly implemented

    Article • Primary Care Respiratory Journal, May 2012, Nature

    Professor David Price

  96. Spirometry: an essential tool for screening, case-finding, and diagnosis of COPD

    Article • Primary Care Respiratory Journal, May 2012, Nature

    Professor David Price

  97. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

    Article • Journal of Allergy and Clinical Immunology, May 2012, Elsevier

    Professor David Price

  98. Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial

    Article • BMJ, March 2012, BMJ

    Professor David Price

  99. Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper

    Article • International Archives of Allergy and Immunology, January 2012, Karger Publishers

    Dr Ioana O Agache, Professor David Price, Adnan Custovic

  100. Effectiveness of Same Versus Mixed Asthma Inhaler Devices: A Retrospective Observational Study in Primary Care

    Article • Allergy Asthma and Immunology Research, January 2012, The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

    Professor David Price

  101. Inhaled Corticosteroid/Long-Acting β2-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe

    Article • International Archives of Allergy and Immunology, January 2012, Karger Publishers

    Professor David Price, Chris Winchester

  102. Practical guide to skin prick tests in allergy to aeroallergens

    Article • Allergy, November 2011, Wiley

    Professor David Price

  103. Cost-utility analysis of indacaterol in Germany: A once-daily maintenance bronchodilator for patients with COPD

    Article • Respiratory Medicine, November 2011, Elsevier

    Professor David Price

  104. New horizons in early stage COPD – Improving knowledge, detection and treatment

    Article • Respiratory Medicine, November 2011, Elsevier

    Professor David Price

  105. The Asthma Control Test (ACT) as an alternative tool to Global Initiative for Asthma (GINA) guideline criteria for assessing asthma control in Vietnamese outpatients

    Article • Primary Care Respiratory Journal, October 2011, Nature

    Professor David Price

  106. Device type and real-world effectiveness of asthma combination therapy: An observational study

    Article • Respiratory Medicine, October 2011, Elsevier

    Professor David Price

  107. Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness

    Article • Current Allergy and Asthma Reports, September 2011, Springer Science + Business Media

    Professor David Price

  108. Detecting mild COPD is not a waste of resources

    Article • Primary Care Respiratory Journal, August 2011, Nature

    Professor David Price

  109. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study

    Article • Clinical & Experimental Allergy, July 2011, Wiley

    Professor David Price

  110. Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy

    Article • New England Journal of Medicine, May 2011, New England Journal of Medicine (NEJM/MMS)

    Professor David Price

  111. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2011, Taylor & Francis

    Professor David Price

  112. A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).

    Article • Health Technology Assessment, May 2011, National Institute for Health Research

    Professor David Price

  113. Inhaler devices for asthma: a call for action in a neglected field

    Article • European Respiratory Journal, April 2011, European Respiratory Society (ERS)

    Professor David Price

  114. Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD

    Article • Journal of Asthma and Allergy, April 2011, Taylor & Francis

    Professor David Price

  115. Clinical trials and tribulations: the MASCOT study

    Article • Thorax, March 2011, BMJ

    Professor David Price

  116. Current Control and Future Risk in Asthma Management

    Article • Allergy Asthma and Immunology Research, January 2011, The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

    Professor David Price

  117. Improving the Differential Diagnosis of Chronic Obstructive Pulmonary Disease in Primary Care

    Article • Mayo Clinic Proceedings, December 2010, Elsevier

    Professor David Price

  118. UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance Knowledge

    Article • Primary Care Respiratory Journal, November 2010, Nature

    Professor David Price

  119. The use of roflumilast in COPD: a primary care perspective

    Article • Primary Care Respiratory Journal, November 2010, Nature

    Professor David Price

  120. Suboptimal persistence with inhaled corticosteroid monotherapy among children with persistent asthma in the UK

    Article • Primary Care Respiratory Journal, October 2010, Nature

    Professor David Price

  121. Earlier diagnosis and earlier treatment of COPD in primary care

    Article • Primary Care Respiratory Journal, September 2010, Nature

    Professor David Price

  122. Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

    Article • Journal of Medicinal Chemistry, September 2010, American Chemical Society (ACS)

    Professor David Price

  123. Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper

    Article • Allergy, September 2010, Wiley

    Professor David Price, Adnan Custovic

  124. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

    Article • Journal of Allergy and Clinical Immunology, September 2010, Elsevier

    Professor David Price, Adnan Custovic

  125. Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs

    Article • Respiratory Medicine, September 2010, Elsevier

    Professor David Price

  126. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: A real-world observational study

    Article • Journal of Allergy and Clinical Immunology, September 2010, Elsevier

    Professor David Price

  127. Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma

    Article • Primary Care Respiratory Journal, June 2010, Nature

    Professor David Price

  128. Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy

    Article • PharmacoEconomics, May 2010, Springer Science + Business Media

    Professor David Price

  129. Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma

    Article • PharmacoEconomics, May 2010, Springer Science + Business Media

    Professor David Price

  130. Improving clinician-patient communication in asthma: the HARP project

    Article • Allergy, April 2010, Wiley

    Professor David Price

  131. What happens to patients who have their asthma device switched without their consent?

    Article • Primary Care Respiratory Journal, February 2010, Nature

    Professor David Price

  132. The feasibility of recruiting patients with early COPD to a pilot trial assessing the effects of a physical activity intervention

    Article • Primary Care Respiratory Journal, February 2010, Nature

    Professor David Price

  133. Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care

    Article • Primary Care Respiratory Journal, January 2010, Nature

    Professor David Price

  134. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

    Article • BMC Pulmonary Medicine, January 2010, Springer Science + Business Media

    Professor David Price

  135. Asthma and allergic rhinitis: Linked in treatment and outcomes

    Article • Annals of Thoracic Medicine, January 2010, Medknow

    Professor David Price

  136. Derivation and Validation of a Composite Index of Severity in Chronic Obstructive Pulmonary Disease

    Article • American Journal of Respiratory and Critical Care Medicine, December 2009, American Thoracic Society

    Professor David Price

  137. The CYMPLA trial. Mobile phone-based strrctrred intervention to achieve asthma control in patients with rncontrolled persistent asthma: a pragmatic randomised controlled trial

    Article • Primary Care Respiratory Journal, November 2009, Nature

    Professor David Price

  138. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ Inhaler

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2009, Taylor & Francis

    Professor David Price

  139. Predictors of asthma control in everyday clinical practice in Switzerland

    Article • Current Medical Research and Opinion, September 2009, Informa Healthcare

    Professor David Price

  140. Unmet needs in severe chronic upper airway disease (SCUAD)

    Article • Journal of Allergy and Clinical Immunology, September 2009, Elsevier

    Professor David Price, Adnan Custovic

  141. Spirometry in primary care case-identification, diagnosis and management of COPD

    Article • Primary Care Respiratory Journal, August 2009, Nature

    Professor David Price, Ms Sian Williams

  142. Screening for and early detection of chronic obstructive pulmonary disease

    Article • The Lancet, August 2009, Elsevier

    Professor David Price

  143. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control

    Article • Primary Care Respiratory Journal, June 2009, Nature

    Professor David Price

  144. Guidelines for allergic rhinitis need to be used in primary care

    Article • Primary Care Respiratory Journal, June 2009, Nature

    Professor David Price

  145. Not all asthma inhalers are the same: factors to consider when prescribing an inhaler

    Article • Primary Care Respiratory Journal, June 2009, Nature

    Professor David Price

  146. Befriending carers of people with dementia: a cost utility analysis

    Article • International Journal of Geriatric Psychiatry, June 2009, Wiley

    Professor David Price

  147. Antibiotic Prescribing and Outcomes of Lower Respiratory Tract Infection in UK Primary Care

    Article • CHEST Journal, May 2009, Elsevier

    Professor David Price, Chris Winchester

  148. Driving asthma care in Europe: the Brussels Declaration

    Article • Primary Care Respiratory Journal, March 2009, Nature

    Professor David Price

  149. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom

    Article • Allergy, March 2009, Wiley

    Professor David Price

  150. The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey

    Article • Primary Care Respiratory Journal, February 2009, Nature

    Professor David Price

  151. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control

    Article • BMC Pulmonary Medicine, January 2009, Springer Science + Business Media

    Professor David Price

  152. High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma: An observational study

    Article • Journal of Allergy and Clinical Immunology, January 2009, Elsevier

    Professor David Price

  153. Prescribing trends in asthma: a longitudinal observational study

    Article • Archives of Disease in Childhood, January 2009, BMJ

    Professor David Price

  154. Achieving asthma control in practice: Understanding the reasons for poor control

    Article • Respiratory Medicine, December 2008, Elsevier

    Professor David Price

  155. The Brussels Declaration: the need for change in asthma management

    Article • European Respiratory Journal, December 2008, European Respiratory Society (ERS)

    Professor David Price

  156. Impact of comorbidities on asthma

    Article • Expert Review of Clinical Immunology, November 2008, Informa Healthcare

    Professor David Price

  157. Breathing exercises for asthma: a randomised controlled trial

    Article • Thorax, October 2008, BMJ

    Professor David Price

  158. Pro-con debate: Inhaled corticosteroids should not be prescribed in primary care to children under two years of age — the case for

    Article • Primary Care Respiratory Journal, August 2008, Nature

    Professor David Price

  159. The current burden of allergic rhinitis amongst primary care practitioners and its impact on patient management

    Article • Primary Care Respiratory Journal, July 2008, Nature

    Professor David Price

  160. Befriending carers of people with dementia: randomised controlled trial

    Article • BMJ, June 2008, BMJ

    Professor David Price

  161. British Guideline on the Management of Asthma

    Article • Thorax, May 2008, BMJ

    Professor David Price, Gary Connett

  162. EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 — a summary

    Article • Primary Care Respiratory Journal, April 2008, Nature

    Professor David Price

  163. The use of omalizumab in asthma

    Article • Primary Care Respiratory Journal, April 2008, Nature

    Professor David Price

  164. Perceptions, impact and management of asthma in South Africa: a patient questionnaire study

    Article • Primary Care Respiratory Journal, April 2008, Nature

    Professor David Price

  165. Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study

    Article • Primary Care Respiratory Journal, April 2008, Nature

    Professor David Price

  166. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

    Article • Allergy, March 2008, Wiley

    Professor David Price, Adnan Custovic

  167. Comparison of Mometasone Furoate Dry Powder Inhaler and Fluticasone Propionate Dry Powder Inhaler in Patients with Moderate to Severe Persistent Asthma Requiring High-Dose Inhaled Corticosteroid Therapy: Findings from a Noninferiority Trial

    Article • Journal of Asthma, January 2008, Taylor & Francis

    Professor David Price

  168. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN

    Article • Allergy, November 2007, Wiley

    Professor David Price

  169. An exploratory, pragmatic, cluster randomised trial of practice nurse training in the use of asthma action plans

    Article • Primary Care Respiratory Journal, October 2007, Nature

    Professor David Price

  170. Concerns of patients with allergic rhinitis: the Allergic Rhinitis Care Programme in South Africa

    Article • Primary Care Respiratory Journal, October 2007, Nature

    Professor David Price

  171. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy

    Article • Allergy, October 2007, Wiley

    Professor David Price

  172. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life

    Article • July 2007, Springer Science + Business Media

    Professor David Price

  173. Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study

    Article • July 2007, Springer Science + Business Media

    Professor David Price

  174. Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma

    Article • Respiratory Medicine, July 2007, Elsevier

    Professor David Price

  175. The UK General Practice Airways Group (GPIAG): its formation, development, and influence on the management of asthma and other respiratory diseases over the last twenty years

    Article • Primary Care Respiratory Journal, May 2007, Nature

    Professor David Price

  176. Can asthma control be improved by understanding the patient's perspective?

    Article • BMC Pulmonary Medicine, May 2007, Springer Science + Business Media

    Professor David Price, Ms Sian Williams

  177. Do people self-reporting information about chronic respiratory disease have corroborative evidence in their general practice medical records? A study of intermethod reliability

    Article • Primary Care Respiratory Journal, May 2007, Nature

    Professor David Price

  178. Understanding the potential role of mobile phone-based monitoring on asthma self-management: qualitative study

    Article • Clinical & Experimental Allergy, May 2007, Wiley

    Professor David Price

  179. Practice development plans to improve the primary care management of acute asthma: randomised controlled trial

    Article • BMC Family Practice, April 2007, Springer Science + Business Media

    Professor David Price

  180. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma

    Article • Current Medical Research and Opinion, April 2007, Informa Healthcare

    Professor David Price

  181. The use of a modification of the Patient Enablement Instrument in asthma

    Article • Primary Care Respiratory Journal, March 2007, Nature

    Professor David Price

  182. Short-Course Montelukast for Intermittent Asthma in Children

    Article • American Journal of Respiratory and Critical Care Medicine, February 2007, American Thoracic Society

    Professor David Price

  183. COPD screening efforts in primary care: what is the yield?

    Article • Primary Care Respiratory Journal, February 2007, Nature

    Professor David Price

  184. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK

    Article • Primary Care Respiratory Journal, February 2007, Nature

    Professor David Price

  185. Standardized training for healthcare professionals and its impact on patients with perennial rhinitis: a multi-centre randomized controlled trial

    Article • Clinical & Experimental Allergy, January 2007, Wiley

    Professor David Price

  186. Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997?2001

    Article • International Journal of COPD, December 2006, Dove Medical Press

    Professor David Price

  187. Treatment and Outcomes in Patients with Asthma and Allergic Rhinitis in the United Kingdom

    Article • International Archives of Allergy and Immunology, November 2006, Karger Publishers

    Professor David Price

  188. Poor communication may impair optimal asthma care: a qualitative study

    Article • Family Practice, October 2006, Oxford University Press (OUP)

    Professor David Price

  189. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)

    Article • Allergy, September 2006, Wiley

    Professor David Price, Adnan Custovic

  190. Impact of antibiotic restrictions: the physician's perspective

    Article • Clinical Microbiology and Infection, August 2006, Elsevier

    Professor David Price

  191. Professional and patient attitudes to using mobile phone technology to monitor asthma: questionnaire survey

    Article • Primary Care Respiratory Journal, August 2006, Nature

    Professor David Price

  192. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial

    Article • Allergy, June 2006, Wiley

    Professor David Price

  193. High-dose inhaled corticosteroids and add-on therapy use in adults with asthma in the UK in 2003: an observational study

    Article • Primary Care Respiratory Journal, June 2006, Nature

    Professor David Price

  194. Scoring System and Clinical Application of COPD Diagnostic Questionnaires

    Article • CHEST Journal, June 2006, Elsevier

    Professor David Price

  195. Sub-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma

    Article • Primary Care Respiratory Journal, June 2006, Nature

    Professor David Price

  196. Symptom-Based Questionnaire for Differentiating COPD and Asthma

    Article • Respiration, May 2006, Karger Publishers

    Professor David Price

  197. Symptom-Based Questionnaire for Identifying COPD in Smokers

    Article • Respiration, May 2006, Karger Publishers

    Professor David Price

  198. ARIA update: I—Systematic review of complementary and alternative medicine for rhinitis and asthma

    Article • Journal of Allergy and Clinical Immunology, May 2006, Elsevier

    Professor David Price

  199. Exacerbations of chronic obstructive pulmonary disease — A patients' perspective

    Article • Primary Care Respiratory Journal, April 2006, Nature

    Professor David Price

  200. Comorbidity among the morbidly obese: a comparative study of 2002 U.S. hospital patient discharges

    Article • Surgery for Obesity and Related Diseases, March 2006, Elsevier

    Professor David Price

  201. International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care

    Article • Primary Care Respiratory Journal, February 2006, Nature

    Professor David Price

  202. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis

    Article • Primary Care Respiratory Journal, February 2006, Nature

    Professor David Price

  203. Asthma out of control? A structured review of recent patient surveys

    Article • BMC Pulmonary Medicine, January 2006, Springer Science + Business Media

    Professor David Price

  204. Breaking new ground: challenging existing asthma guidelines

    Article • BMC Pulmonary Medicine, January 2006, Springer Science + Business Media

    Professor David Price

  205. Improving outcomes for asthma patients with allergic rhinitis: conclusions from the MetaForum conferences

    Article • BMC Pulmonary Medicine, January 2006, Springer Science + Business Media

    Professor David Price

  206. Misdiagnosis of COPD and Asthma in Primary Care Patients 40 Years of Age and Over

    Article • Journal of Asthma, January 2006, Taylor & Francis

    Professor David Price

  207. Progressive breathlessness in COPD — The role of hyperinflation and its pharmacological management

    Article • Primary Care Respiratory Journal, December 2005, Nature

    Professor David Price

  208. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

    Article • European Respiratory Journal, November 2005, European Respiratory Society (ERS)

    Professor David Price

  209. Achieving optimal asthma control: Can this be informed by recent studies of professional-patient communication?

    Article • Primary Care Respiratory Journal, October 2005, Nature

    Professor David Price

  210. Is Living in a Rural Area Good for Your Respiratory Health?

    Article • CHEST Journal, October 2005, Elsevier

    Professor David Price

  211. Questions for COPD diagnostic screening in a primary care setting

    Article • Respiratory Medicine, October 2005, Elsevier

    Professor David Price

  212. Gastroesophageal Reflux Disease and Asthma

    Article • CHEST Journal, July 2005, Elsevier

    Professor David Price

  213. Mobile phone technology in the management of asthma

    Article • Journal of Telemedicine and Telecare, July 2005, SAGE Publications

    Professor David Price

  214. The prevalence of dysfunctional breathing in adults in the community with and without asthma

    Article • Primary Care Respiratory Journal, April 2005, Nature

    Professor David Price

  215. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults

    Article • Clinical & Experimental Allergy, March 2005, Wiley

    Professor David Price

  216. The national montelukast survey

    Article • Journal of Allergy and Clinical Immunology, January 2005, Elsevier

    Professor David Price

  217. Development of a primary-care tool to assess treatment success in COPD: consensus report from a closed meeting of respiratory and primary-care specialists

    Article • Primary Care Respiratory Journal, June 2004, Nature

    Professor David Price

  218. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study

    Article • Current Medical Research and Opinion, May 2004, Informa Healthcare

    Professor David Price

  219. Adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study

    Article • Respiratory Medicine, May 2004, Elsevier

    Professor David Price

  220. Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice

    Article • Respiratory Medicine, January 2004, Elsevier

    Professor David Price, Chris Winchester

  221. Chronic cough

    Article • BMJ, May 2003, BMJ

    Professor David Price

  222. Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial

    Article • BMJ, March 2003, BMJ

    Professor David Price

  223. Database studies in asthma pharmacoeconomics: uses, limitations and quality markers

    Article • Expert Opinion on Pharmacotherapy, March 2003, Informa Healthcare

    Professor David Price

  224. Pharmacoeconomics of asthma treatment

    Article • Expert Opinion on Pharmacotherapy, March 2003, Informa Healthcare

    Professor David Price

  225. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

    Article • Thorax, March 2003, BMJ

    Professor David Price

  226. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI) Allergic Rhinitis and its Impact on Asthma (ARIA)

    Article • Allergy, March 2003, Wiley

    Professor David Price

  227. Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial

    Article • Thorax, February 2003, BMJ

    Professor David Price

  228. Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device

    Article • Respiratory Medicine, January 2003, Elsevier

    Professor David Price

  229. Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose

    Article • Thorax, September 2002, BMJ

    Professor David Price

  230. Clinically Important Improvements in Asthma-Specific Quality of Life, But No Difference in Conventional Clinical Indexes in Patients Changed From Conventional Beclomethasone Dipropionate to Approximately Half the Dose of Extrafine Beclomethasone Diprop...

    Article • CHEST Journal, June 2002, Elsevier

    Professor David Price

  231. Guided self management plans for asthma

    Article • BMJ, May 2001, BMJ

    Professor David Price

  232. Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.

    Article • Respiratory Medicine, January 2001, Elsevier

    Professor David Price

  233. Present and future management of asthma and COPD: proceedings from WONCA 1998

    Article • Family Practice, June 1999, Oxford University Press (OUP)

    Professor David Price

  234. Salmeterol xinafoate: an analysis of outcomes and cost-effectiveness using a primary care database

    Article • Respiratory Medicine, November 1998, Elsevier

    Professor David Price

  235. Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care

    Article • Respiratory Medicine, February 1998, Elsevier

    Professor David Price

  236. A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice

    Article • Cephalalgia, February 1997, SAGE Publications

    Professor David Price